EBAC
European Biotech Acquisition Corp. Class A Ordinary Shares
EBAC
EBAC
Delisted
EBAC was delisted on the 2nd of March, 2023.
50 hedge funds and large institutions have $86.6M invested in European Biotech Acquisition Corp. Class A Ordinary Shares in 2022 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 5 increasing their positions, 3 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
50
Holders Change
+4
Holders Change %
+8.7%
% of All Funds
0.86%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
5
Reduced
3
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
BNP Paribas Financial Markets
Paris,
France
|
+$3.69M |
| 2 |
PC
Periscope Capital
Toronto,
Ontario, Canada
|
+$3.34M |
| 3 |
GCL
Glazer Capital LLC
New York
|
+$2.84M |
| 4 |
FTCM
First Trust Capital Management
Chicago,
Illinois
|
+$2.27M |
| 5 |
MF
Magnetar Financial
Evanston,
Illinois
|
+$1.31M |